Metagen Therapeutics — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

A microbiome company developing live bacterial therapeutics for infectious and other diseases.

Infectious DiseaseGastroenterology

A platform combining metagenomics and proprietary bacterial cultivation to discover and develop defined consortia of live bacteria as therapeutics.

Addressing the urgent global threat of antimicrobial resistance with novel, microbiome-modulating treatments for infections.

Scientific and regulatory risks associated with the complexity of live bacterial drugs and demonstrating consistent clinical efficacy.

Competes in the high-risk, high-reward microbiome therapeutics space against several well-funded US and European companies.